Rx oral solid opioids market share for morphine equivalents U.S. 2017, by drug

Codeine had a two percent share of the total U.S. market of prescription oral solid opioids based on morphine equivalents sold in 2017. However, based on morphine equivalents sold, oxycodone was by far the leading Rx oral solid opioid, with a market share of 46 percent.

Percentage of the prescription oral solid opioid market in the U.S. based on morphine equivalents (MEQ) in 2017, by drug

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

January 2019

Region

United States

Survey time period

2017

Supplementary notes

Morphine equivalents are a standardized measure used in this study to compare the relative potency of a milligram of each opioid to morphine.
Statistic includes prescription retail and hospital markets.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.